TNF and COVID-19: These results seem to contrast with the evidence obtained by Karki et al., who demonstrated that the combination of IFN-γ and TNF-α was able to recapitulate the cellular and tissue damages observed in severe COVID-19 patients with acute respiratory distress syndrome (ARDS), both in vitro cultures and in vivo animal models.